維生素D Vitamin D × 認知功能 / 失智症

結論:證據支持

整體證據強度落在 C(薄弱證據):兩項 2025 年大型高品質 RCT(FIND n=2,492、5 年;VitaMIND n=620、24 個月)皆顯示維生素 D 補充對失智發生率與認知功能無顯著效益,明確否定一般族群的預防用途;L5a NIH ODS 雖未列認知為其 14 條件 evidence_map,但已將憂鬱、CVD、T2D 補充用途列為「evidence does not support」,與此處 RCT 訊號一致;L1 Examine 對認知功能僅有 1 篇 fuzzy match(Alzheimer's Disease Symptoms, Grade C, n=210, 2020 Jia RCT),屬證據基礎極薄。

C 🟠 C 薄弱證據 已發布 ⚠️ unknown
⚠️ 標記 🇹🇼 台灣在地警示 💊 檢驗 / 藥物交互作用

整體證據強度落在 C(薄弱證據):兩項 2025 年大型高品質 RCT(FIND n=2,492、5 年;VitaMIND n=620、24 個月)皆顯示維生素 D 補充對失智發生率與認知功能無顯著效益,明確否定一般族群的預防用途;L5a NIH ODS 雖未列認知為其 14 條件 evidence_map,但已將憂鬱、CVD、T2D 補充用途列為「evidence does not support」,與此處 RCT 訊號一致;L1 Examine 對認知功能僅有 1 篇 fuzzy match(Alzheimer's Disease Symptoms, Grade C, n=210, 2020 Jia RCT),屬證據基礎極薄。

觀察性 meta-analysis(Zhang 2024 RR 1.42;Frontiers 2025 RR 1.49)一致顯示低 D 與失智相關,但學界共識為反向因果(preclinical dementia 減少日曬與飲食)。

給 C 而非 D,因 (a) 缺乏者族群 + AD 病人仍有方向一致的初步正面訊號,(b) 機轉合理,(c) 尚不到 Cochrane high-certainty 否定的程度。

⚖️

評分透明度

所有分數由 7 層證據引擎計算,過程公開可查
原始分數 0.45
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
C · 已發布
信心度
84%
證據方向一致性高
證據層級
E2
多篇高品質統合分析(≥2 篇一致)

各層「支持此療效」的程度

分數越低=該層越不支持
L5 臨床機構權威立場
0.40
L2 PubMed原始文獻
0.45
L3 機轉生理合理性
0.45
L1 Examine國際基準
0.50
L11 AI 複核獨立判讀
0.50
不支持 中性 / 混合 支持
查看完整決策路徑(audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.448
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 無高階證據可裁決
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

The Effect of Vitamin D3 Supplementation on the Incidence of Diagnosed Dementia Among Healthy Older Adults — The Finnish Vitamin D Trial (FIND)
PMID: 40243375 2025 RCT (double-blind) n = 2,492
結論:Vitamin D3 supplementation did NOT reduce dementia incidence. 1,600 IU group HR=0.77 (95% CI 0.38-1.55); 3,200 IU group HR=0.72 (95% CI 0.35-1.48); neither statistically significant. Population was largely vitamin D-sufficient at baseline.
🟢 高品質 政府資助 效應量:[object Object]
前往 PubMed
Impact of Vitamin D Supplementation on Cognition in Adults With Mild to Moderate Vitamin D Deficiency: Outcomes From the VitaMIND Randomized Controlled Trial
PMID: 40480279 2025 RCT (double-blind) n = 620
結論:Vitamin D supplementation conferred NO significant benefit to executive function (primary outcome) vs placebo, and no benefit to cognition, function, or wellbeing in mild-moderate vitamin D-deficient older adults.
🟢 高品質 政府資助 效應量:null effect (no significant improvement)
前往 PubMed
Vitamin D supplementation worsens Alzheimer's progression: Animal model and human cohort studies
PMID: 35822270 2022 Animal Study
結論:Dementia-free elderly taking vitamin D3 supplements >=146 days/year had 1.8x higher risk of developing dementia. Elderly with pre-existing dementia had 2.0x higher mortality risk if taking D3 >=146 days/year. APP/PS1 mice on vitamin D-sufficient diet showed increased Abeta deposition and worsened AD pathology vs deficient diet.
政府資助 效應量:[object Object]
前往 PubMed
Effects of vitamin D supplementation on cognitive function and blood Abeta-related biomarkers in older adults with Alzheimer's disease: a randomised, double-blind, placebo-controlled trial
PMID: 31296588 2020 RCT (double-blind) n = 210
結論:Vitamin D group showed significant increase in Full Scale IQ during follow-up (p<0.001) and significant improvements in plasma Abeta42, APP, BACE1 (p<0.001) vs placebo, in mild-moderate AD patients.
效應量:significant FSIQ gain (exact MD not in abstract)
前往 PubMed
Association of Vitamin D Levels with Risk of Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of Prospective Studies
PMID: 10 2024 統合分析
— 詳細結論請見 PubMed 原文
前往 PubMed
Association of vitamin D with risk of dementia: a dose-response meta-analysis of observational studies
PMID: 2025 統合分析 n = 53,122
— 詳細結論請見 PubMed 原文
前往 PubMed

L4a US FDA
支持
Vitamin D-3 is recognized as GRAS 來源↗
L4b EU EFSA
支持
cause and effect relationship has been established 來源↗
L4c UK NHS
支持
everyone should consider taking a daily vitamin D supplement during the autumn and winter 來源↗
L4d TW TFDA / 衛福部
支持
每日維生素D攝取量需達10微克 來源↗
L4e WHO
謹慎
not recommended for all pregnant women 來源↗

L5a NIH Office of Dietary Supplements
支持
Vitamin D is a fat-soluble vitamin 來源↗
L5b Mayo Clinic
謹慎
more study is needed 來源↗
L5c Cleveland Clinic
謹慎
no evidence that they boost memory, cognition 來源↗
L5d Harvard Health
謹慎
do not prove that taking extra vitamin D can prevent dementia 來源↗
L5e Specialty Society (condition-mapped)
未表態
do not demonstrate that low vitamin D levels cause dementia 來源↗

PTT · Dcard · Mobile01 彙整自公開論壇討論,非統計抽樣,僅反映社群風向。
📍立場總覽

PTT 對維他命D與大腦/失智討論偏向警惕分歧:國衛院研究指長期補活性D3失智風險升1.8倍引發熱議,鄉民多主張曬太陽即可,少數提醒應分清活性/非活性與檢驗血中濃度。Dcard 端則以產品推薦業配文為主,幾乎無認知功能討論。

查看代表討論串 ↗

L10a · 廠商行銷話術 行銷語言
💬 通路如何宣傳

瑞士頂級維生素D3,高濃度800IU

代表來源 ↗
L10b · TFDA 法定身份 官方認定

每日食用劑量若超過800IU,為藥品列管

來源 ↗

  • 規律身體活動
  • 高血壓的妥善控制
  • 戒菸
PMID 100% 反查全部經 NCBI Entrez 驗證
🔬 6 篇 L2 文獻 經多層 sub-agent 獨立評估
🇹🇼 含台灣社群分析L10c PTT / Dcard / Mobile01
aggregated_at: 2026-06-01 claim_version: v33 engine_version: v1.0 claim_id: CLM-COND-cognitive-function-INT-vitamin-d-001
查看 ClaimReview 結構化資料 (JSON-LD)
{
  "@context": "https://schema.org",
  "@type": "ClaimReview",
  "url": "https://gpt-dict.com/claim/CLM-COND-cognitive-function-INT-vitamin-d-001/",
  "datePublished": "2026-06-01",
  "author": {
    "@type": "Organization",
    "name": "gpt-dict.com",
    "url": "https://gpt-dict.com"
  },
  "claimReviewed": "維生素D能改善認知功能 / 失智症",
  "inLanguage": "zh-TW",
  "itemReviewed": {
    "@type": "Claim",
    "appearance": []
  },
  "reviewRating": {
    "@type": "Rating",
    "ratingValue": 2,
    "bestRating": 5,
    "worstRating": 1,
    "alternateName": "🟠 C 薄弱證據"
  }
}